(Q54396638)

29 May 2018

title

CD4+ helper T cells are required for resistance to a highly metastatic murine tumor. (English)

1 reference

29 May 2018

author name string

Schild HJ

1

1 reference

29 May 2018

Kyewski B

2

1 reference

29 May 2018

Von Hoegen P

3

1 reference

29 May 2018

Schirrmacher V

4

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 December 1987

1 reference

29 May 2018

European Journal of Immunology

published in

1 reference

29 May 2018

volume

17

1 reference

29 May 2018

page(s)

1863-1866

1 reference

29 May 2018

issue

12

1 reference

29 May 2018

Regulatory Mechanisms in the Immune Response to Cell-surface Antigens

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Antigenic variation in cancer metastasis: immune escape versus immune control

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Islet allograft survival after a single course of treatment of recipient with antibody to L3T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Capacity of purified Lyt-2+ T cells to mount primary proliferative and cytotoxic responses to Ia- tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

High determinant density may explain the phenomenon of alloreactivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Influence of dendritic cells on tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830171231

7 January 2021

Identifiers

DOI

10.1002/EJI.1830171231

1 reference

29 May 2018

PubMed ID

2961578

1 reference

29 May 2018